Bristol-Myers Squibb and the Medicines Patent Pool - An Unlikely Marriage?

被引：0

作者：

Chu, Rachel ^{[1
]}

机构：

[1] Maastricht Univ, Law Fac, Maastricht, Netherlands

来源：

EUROPEAN JOURNAL OF RISK REGULATION | 2014年 / 5卷 / 01期

关键词：

D O I：

10.1017/Si867299XO000297X

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

引用

收藏

页码：68 / 72

页数：5

相关论文

共 50 条

[21] AstraZeneca (Sweden)/Bristol-Myers Squibb (UK)
不详
JOURNAL OF DIABETES, 2009, 1 (04) : 232 - 233
[22] BRISTOL-MYERS SQUIBB BUILDS BIOLOGICS PLANT
不详
CHEMICAL & ENGINEERING NEWS, 2014, 92 (47) : 14 - 14
[23] Is Aventis following in the footsteps of Bristol-Myers Squibb?
不详
ANNALS OF ONCOLOGY, 2002, 13 (07) : 989 - 989
[24] The patient labeling program at Bristol-Myers Squibb
O'Connell, CA
Skinner, R
DRUG INFORMATION JOURNAL, 1999, 33 (03): : 649 - 654
[25] Technology evaluation: Abatacept, bristol-myers squibb
Dumont, FJ
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (03) : 318 - 330
[26] Bristol-Myers Squibb to buy tech center
不详
CHEMICAL & ENGINEERING NEWS, 1997, 75 (26) : 20 - 20
[27] Bristol-Myers Squibb rapped over generics
不详
CHEMISTRY & INDUSTRY, 2003, (06) : 7 - 7
[28] Bristol-Myers Squibb strengthens commitment to hepatitis research
不详
DRUG NEWS & PERSPECTIVES, 1997, 10 (08) : 476 - 476
[29] Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
不详
BIOPHARM INTERNATIONAL, 2014, 27 (09) : 12 - 12
[30] Technology evaluation: Belatacept, Bristol-Myers Squibb
Vanhove, B
Soulillou, JP
CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (04) : 384 - 393

← 1 2 3 4 5 →